1. Home
  2. GIFI vs ATOS Comparison

GIFI vs ATOS Comparison

Compare GIFI & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIFI
  • ATOS
  • Stock Information
  • Founded
  • GIFI 1985
  • ATOS 2009
  • Country
  • GIFI United States
  • ATOS United States
  • Employees
  • GIFI N/A
  • ATOS N/A
  • Industry
  • GIFI Metal Fabrications
  • ATOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GIFI Industrials
  • ATOS Health Care
  • Exchange
  • GIFI Nasdaq
  • ATOS Nasdaq
  • Market Cap
  • GIFI 111.5M
  • ATOS 107.2M
  • IPO Year
  • GIFI 1997
  • ATOS 2012
  • Fundamental
  • Price
  • GIFI $6.72
  • ATOS $0.83
  • Analyst Decision
  • GIFI
  • ATOS Strong Buy
  • Analyst Count
  • GIFI 0
  • ATOS 3
  • Target Price
  • GIFI N/A
  • ATOS $6.17
  • AVG Volume (30 Days)
  • GIFI 32.0K
  • ATOS 1.4M
  • Earning Date
  • GIFI 08-12-2025
  • ATOS 08-11-2025
  • Dividend Yield
  • GIFI N/A
  • ATOS N/A
  • EPS Growth
  • GIFI N/A
  • ATOS N/A
  • EPS
  • GIFI 0.74
  • ATOS N/A
  • Revenue
  • GIFI $156,591,000.00
  • ATOS N/A
  • Revenue This Year
  • GIFI N/A
  • ATOS N/A
  • Revenue Next Year
  • GIFI N/A
  • ATOS N/A
  • P/E Ratio
  • GIFI $9.23
  • ATOS N/A
  • Revenue Growth
  • GIFI 18.83
  • ATOS N/A
  • 52 Week Low
  • GIFI $5.12
  • ATOS $0.55
  • 52 Week High
  • GIFI $7.59
  • ATOS $1.66
  • Technical
  • Relative Strength Index (RSI)
  • GIFI 44.34
  • ATOS 46.18
  • Support Level
  • GIFI $6.68
  • ATOS $0.84
  • Resistance Level
  • GIFI $6.96
  • ATOS $0.98
  • Average True Range (ATR)
  • GIFI 0.20
  • ATOS 0.05
  • MACD
  • GIFI -0.04
  • ATOS -0.00
  • Stochastic Oscillator
  • GIFI 6.45
  • ATOS 14.12

About GIFI Gulf Island Fabrication Inc.

Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: